How Analysts Rate Accenture Post Q4 Results?

Loading...
Loading...
  • Analysts mostly lauded Accenture PLC's ACN Q4 results and FY22 outlook, slightly cautioned by the Q4 revenue miss.
  • Related ContentAccenture Clocks 24% Revenue Growth In Q4, Hikes Dividend, Adds $3B Share Buyback
  • Piper Sandler analyst Arvind Ramnani bumped the PT to $354 from $302, suggesting a 3.2% upside, and kept a Neutral rating.
  • Citi analyst Ashwin Shirvaikar raised the PT to $390 from $340, implying a 13.7% upside, and reiterated a Buy.
  • Morgan Stanley analyst James Faucette lifted the PT to $400 from $380, indicating a 16.6% upside, and maintained an Overweight.
  • Argus analyst Jim Kelleher raised the PT to $400 from $330 and affirmed a Buy.
  • Price Action: ACN shares traded lower by 0.23% at $342.32 on the last check Friday.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: NewsPrice TargetReiterationAnalyst RatingsTechBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...